platinum has been researched along with Plasmacytoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leach, MO; Robins, AB | 1 |
| Braddock, PD; Connors, TA; Jones, M; Khokhar, AR; Ross, WC; Tobe, ML | 1 |
| Audette, RC; Connors, TA; Mandel, HG; Merai, K; Ross, WC | 1 |
3 other study(ies) available for platinum and Plasmacytoma
| Article | Year |
|---|---|
Pharmacokinetics of therapeutic doses of isotopically labeled platinum antitumor agents in the mouse and rat.
Topics: Animals; Carbon Radioisotopes; Cell Line; Cisplatin; Kinetics; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Organoplatinum Compounds; Plasmacytoma; Platinum; Radioisotopes | 1983 |
New platinum complexes with anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Female; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Plasmacytoma; Platinum; Structure-Activity Relationship | 1972 |
Studies on the mechanism of action of the tumour inhibitory triazenes.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Dealkylation; Leucine; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Platinum; Thymidine; Time Factors; Transplantation, Homologous; Triazenes; Tritium; Uridine | 1973 |